Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 81.57
-0.21 (-0.26%)
At close: Dec 5, 2025
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 33.30 billion as of December 5, 2025. Its market cap has increased by 4.44% in one year.
Market Cap
33.30B
Enterprise Value
32.61B
Revenue
3.34B
Ranking
n/a
PE Ratio
35.31
Stock Price
81.57
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 33.30B, an increase of 131.87%. That is a compound annual growth rate of 15.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 33.30B | 11.56% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 404.96B |
| WuXi AppTec | 267.37B |
| Shenzhen Mindray Bio-Medical Electronics | 241.27B |
| Sichuan Biokin Pharmaceutical | 149.34B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 104.39B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.40B |